IL6 and neoplasm: It is conceivable that we could achieve a similar, modern objective of “cancer interception” [Domchek and Vonderheide, 2024] by suppressing tumor-associated inflammation and normalization of IL-6 that is not only central to the pathogenesis of glioblastoma, multiple other forms of cancer, as well as diverse neurological illnesses [Pons-Espinal et al., 2024; Robert et al., 2023].